[1]张慧,姜璐,陈俊生,等.国医大师李佃贵基于“浊毒”理论辨治慢性萎缩性胃炎癌前病变胃黏膜屏障功能障碍[J].西部中医药,2024,37(08):47-50.[doi:10.12174/j.issn.2096-9600.2024.08.12]
　ZHANG Hui,JIANG Lu,CHEN Junsheng,et al.National Master of TCM Li Diangui′s Experience in Differentiating and Treating Gastric Mucosal Barrier of Precancerous Lesions in Chronic Atrophic Gastritis Based on "Turbidity-toxin" Theory[J].Western Journal of Traditional Chinese Medicine,2024,37(08):47-50.[doi:10.12174/j.issn.2096-9600.2024.08.12]
点击复制

国医大师李佃贵基于“浊毒”理论辨治慢性萎缩性胃炎癌前病变胃黏膜屏障功能障碍
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年08期
页码:
47-50
栏目:
学术探讨
出版日期:
2024-08-15

文章信息/Info

Title:
National Master of TCM Li Diangui′s Experience in Differentiating and Treating Gastric Mucosal Barrier of Precancerous Lesions in Chronic Atrophic Gastritis Based on "Turbidity-toxin" Theory
作者:
张慧1,2, 姜璐3, 陈俊生1, 张云松3, 李佃贵,,,
1.山东中医药大学，山东 济南 250014
2.济南市中医医院，山东 济南 250014
3.山东中医药大学附属医院，山东 济南 250014
4.河北省中医院，河北 石家庄 050011
Author(s):
ZHANG Hui1,2, JIANG Lu3, CHEN Junsheng1, ZHANG Yunsong3, Director: LI Diangui,,,
1.Shandong University of Traditional Chinese Medicine, Jinan 250014, China
2.Jinan Hospital of Traditional Chinese Medicine, Jinan 250014, China
3.Affiliated Hospital to Shandong University of Traditional Chinese Medicine, Jinan 250014, China
关键词:
萎缩性胃炎; 浊毒; 癌前病变; 胃黏膜屏障
Keywords:
chronic atrophic gastritis; turbidity toxin; precancerous lesions; gastric mucosal barrier
分类号:
R221
DOI:
10.12174/j.issn.2096-9600.2024.08.12
文献标志码:
A
摘要:
国医大师李佃贵以“浊毒”理论为指导，基于本病脾虚毒损胃络的病机特点，分别采用化浊解毒、补虚荣络、祛瘀通络的治法以改善或增强胃黏膜屏障功能，降低慢性萎缩性胃炎癌变率。
Abstract:
Under the guidance of "turbidity toxin" theory, based on the pathogenesis of spleen deficiency and toxin damaged stomach collateral, national master of TCM Li Diangui adopted resolving turbidity and detoxifying, tonifying the deficiency and nourishing the collateral, removing stasis and dredging the collateral respectively to improve or enhance gastric mucosal barrier function and reduce the rate of carcinogenesis of chronic atrophic gastritis (CAG).

相似文献/References:

[1]樊斗霜.枳实消痞丸(汤)合丹参饮加减治疗慢性萎缩性胃炎32例[J].西部中医药,2013,26(02):72.
　FAN Doushuang.Modified ZhiShi XiaoPiWan(Prescription) and DanShenYin in Treating 32 Cases of Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2013,26(08):72.
[2]钟建,王仕琦,唐农.“浊毒”理论在慢性肾衰竭中的应用研究[J].西部中医药,2013,26(07):121.
　ZHONG Jian,WANG Shiqi,TANG Nong.Application of “Turbidity-toxin” Theory to Chronic Renal Failure[J].Western Journal of Traditional Chinese Medicine,2013,26(08):121.
[3]李晶,王捷虹.半夏泻心汤加减对幽门螺旋杆菌相关性萎缩性胃炎患者胃泌素、胃蛋白酶的影响[J].西部中医药,2023,36(09):5.[doi:10.12174/j.issn.2096-9600.2023.09.02]
　LI Jing,WANG Jiehong.Effects of Modified Banxia Xiexin Tang on Gastrin and Pepsin in Patients with Helicobacter pylori Associated Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2023,36(08):5.[doi:10.12174/j.issn.2096-9600.2023.09.02]
[4]李盟,赵迪,杜燕青,等.参佛胃康治疗慢性萎缩性胃炎胃癌前病变作用机制研究[J].西部中医药,2024,37(09):30.[doi:10.12174/j.issn.2096-9600.2024.09.07]
　LI Meng,ZHAO Di,DU Yanqing,et al.Study on the Mechansim of Shenfo Weikang in the Treatment of Precancerous Lesions of Gastric Cancer: Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2024,37(08):30.[doi:10.12174/j.issn.2096-9600.2024.09.07]

备注/Memo

备注/Memo:
张慧（1995—），女，硕士学位，医师。研究方向：脾胃病的中医药防治。国家中医药管理局第六批全国老中医药专家学术经验继承项目（2018—2019）；山东省中医药管理局齐鲁医派中医药特色技术推广项目。
更新日期/Last Update: 2024-08-15